Cohesin, the tool used by doctors to treat gout, can increase the lifespan of people with myocardial infarction, says Zee News. Gout is a joint disease associated with the deposition on the articular surfaces of uric acid salts.
In addition to its primary action, cohesin reduces inflammation. Scientists have suggested that the tool can help in acute coronary syndrome, and they were right. In a randomized study involved 83 people.
Reception of cochicine when experiencing heart attack reduced levels of cytokines, a group of substances called inflammatory markers. While scientists can't answer the question of how the tool operates on the formation of cytokines. It is planned to continue research in this direction.